Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Acute pancreatitis presented with diffuse ST-segment elevation: A case report and literature review.
Medicine (Baltimore)
February 2024
MacKay Medical College, New Taipei City, Taiwan.
Introduction: Although electrocardiographic changes have been previously reported in patients with acute pancreatitis, diffuse ST-segment elevation without occluded coronary arteries is rarely documented.
Patient Concerns: A 45-year-old man presented to our emergency department due to persistent epigastric pain for 2 hours. However, ECG in the emergency department revealed regular sinus rhythm at 67 beats per minute, peaked T waves in lead V3-5, and upsloping ST-segment elevation in leads II, III, aVF, and V2-6.
Acute Cholecystitis Presenting With Atypical Radiologic or Laboratory Findings: A Case Report.
Cureus
June 2023
Internal Medicine, Larkin Community Hospital, Hialeah, USA.
Acute cholecystitis is the most common presentation of gallbladder (GB) disease. It has an incidence of around 200,000 cases a year in the United States (US) and affects approximately 20 million individuals in the US. In most cases, it presents with a history of symptomatic gallstones.
View Article and Find Full Text PDFRepeated cardiac arrest caused by an air embolism during hepatic resection: A case report.
Medicine (Baltimore)
September 2018
Department of Anesthesia, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China.
Rationale: Although venous air embolism (VAE) during liver operation has been reported occasionally, fatal VAE in hepatic resection is uncommon. Prompt detection of VAE by transesophageal echocardiography (TEE) is crucial for effective therapy. We describe a case of fatal VAE that caused repeated cardiac arrest during hepatic resection and was confirmed by TEE.
View Article and Find Full Text PDFCase 27-2017. A 32-Year-Old Man with Acute Chest Pain.
N Engl J Med
August 2017
From the Departments of Medicine (D.E.D., D.M.D.), Radiology (M.P.M.), Surgery (C.F.-C.), and Pathology (J.H.C.), Massachusetts General Hospital and the Departments of Medicine (D.E.D., D.M.D.), Radiology (M.P.M.), Surgery (C.F.-C.), and Pathology (J.H.C.), Harvard Medical School - both in Boston.
Pasireotide monotherapy in Cushing's disease: a single-centre experience with 5-year extension of phase III Trial.
Pituitary
December 2014
Division of Endocrinology, Department of Medicine and Research Center, Centre Hospitalier de l'Université de Montréal (CHUM)-Hotel-Dieu, 3850 Saint-Urbain Street, Montreal, QC, H2W 1T8, Canada.
Purpose: A recent phase III randomized controlled trial (NCT00434148) showed efficacy of pasireotide in the treatment of patients with Cushing's disease (CD). Patients were invited to participate in an extension phase of the protocol and a subgroup had a sustained response. We report the experience with 4 patients in our center of which 2 full responders have completed 5.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!